Organigram Global reported record third-quarter fiscal 2026 revenue of C$105.8 million, a 49% year-over-year increase, and adjusted EBITDA of C$13.4 million, up 136%, driven largely by the acquisition of Germany-based Sanity Group and improved Canadian operations. Sanity Group, acquired on April 15, contributed approximately C$40 million in quarterly revenue, lifting international operations to about 35% of consolidated revenue. The company reaffirmed its fiscal 2026 revenue forecast of more than C$350 million and expects positive free cash flow in the fourth quarter, despite a C$3.9 million free cash outflow in Q3 due to working-capital investments for German demand. Organigram is pursuing EU GMP certification to improve margins and address flower-supply constraints in Europe.
OrganiGram Holdings IncRecord Q3 revenue and EBITDA beat, reaffirmed guidance, and positive free cash flow outlook.
Acquisition contributed ~C$40M quarterly revenue, lifting international operations to 35% of consolidated revenue.
